Lumpy skin disease in cattle and buffaloes is one of the most dangerous infectious livestock diseases, capable of spreading rapidly and causing major losses to the livestock sector. The disease reduces productivity and product quality while directly affecting farmers’ incomes.

According to the Department of Livestock Production and Animal Health, 12 outbreaks were recorded in four provinces and cities nationwide from the beginning of the year to early March 2026. A total of 43 animals were infected, including eight that died or were culled.

Although the number of outbreaks remains limited, the risk of wider transmission persists, particularly amid alternating hot weather and rain combined with high humidity, conditions favourable for blood-sucking insects that transmit the disease.

AVAC LSD LIVE is a vaccine developed and produced by AVAC Vietnam Joint Stock Company for the prevention of lumpy skin disease in cattle and buffaloes. The product underwent rigorous testing for quality, safety and efficacy before export. AVAC is the first Vietnamese company to export an LSD vaccine.

The shipment includes one million 10-dose AVAC LSD LIVE vaccine units and 100,000 five-dose units.

Dr. Nguyen Van Diep, Chief Executive Officer of AVAC Vietnam Joint Stock Company, said the company had gone through extensive preparations for the contract, from research and product development to quality assessment and completion of documentation in line with international standards.

Vaccine samples were sent to World Organisation for Animal Health reference laboratories in Europe for evaluation before the company participated in the bidding process.

Beyond lumpy skin disease vaccines, AVAC is also expanding exports of African swine fever vaccine. The company has so far exported around one million doses to the Philippines and Indonesia.

According to AVAC, the Philippines is preparing to approve the vaccine for commercial circulation after the country’s veterinary authorities assessed the product as safe and effective.

Domestically, AVAC has sold more than 5.5 million doses of African swine fever vaccine, with major livestock enterprises using hundreds of thousands of doses each month. Besides the Philippines and Indonesia, the company is also pursuing product registration in India, Malaysia and Ukraine.

Dr. Nguyen Thi Huong, Chairwoman of the Vietnam Veterinary Science and Technology Association, said the export of a veterinary vaccine researched and produced by a Vietnamese company to the RoK demonstrates the increasingly strong scientific, technological and manufacturing capabilities of Vietnam’s veterinary sector, as well as its growing international integration.

According to Huong, AVAC’s success contributes to animal disease control while confirming Vietnam’s direction in developing veterinary biotechnology, promoting innovation and raising the value of the livestock sector toward a more modern and sustainable model.

Vietnam seeks GAVI support to expand access to new vaccines

VOV.VN - Deputy Minister of Health Nguyen Thi Lien Huong held a meeting with a delegation from the Global Alliance for Vaccines and Immunization (GAVI), calling for continued support to expand access to new vaccines and enhance the sustainability of Vietnam’s national immunisation programme.